Android Apple

Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance

By Yahoo! Finance   |   4 months ago
Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance

Conestoga Capital Advisors' Q2 2024 investor letter discusses the moderation in economic indicators, impacting equity markets. Their Micro-Cap Strategy underperformed due to negative stock selection effects. Mesa Laboratories, Inc. was highlighted as a promising investment despite not being among the top holdings.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.